Bankrupt Purdue Pitches $5.39M Exec Payment Plan

By Dorothy Atkins · June 29, 2021, 6:12 PM EDT

Purdue Pharma asked a New York bankruptcy court Monday to approve the OxyContin drugmaker's 2021 employee incentive and retention plans, which propose to pay its top five executives up to $5.39...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Motion

Case Information

Case Title

Purdue Pharma L.P.

Case Number

Court

New York Southern

Nature of Suit

Date Filed

September 15, 2019

Recent Articles By Dorothy

November 01, 2024
Elevance Says Flawed Medicare Rating System Cost It $375M
October 04, 2024
NJ, Ethics Board Must Hand Over Docs In Retaliation Fight
August 30, 2024
Align Tech Cuts $27.5M Antitrust Deal With 1.45M Consumers
August 29, 2024
Sutter Health Kickback Fight Likely Headed To Nov. Trial
August 23, 2024
Ohio Constitution Dooms 24-Hour Abortion Waiting Period
August 21, 2024
Tobacco Cos. Ask Justices To Review FDA's New Warnings
August 13, 2024
Janssen Wants New FCA Trial As Relators Seek $1.85B Win
August 09, 2024
Split 9th Circ. Affirms Ax Of Meta Anti-Vax Censorship Suit
August 05, 2024
Fla. Man Gets 44 Months For $5M MilliporeSigma Export Scam
July 18, 2024
Abbott Wins Trust Asset Freeze To Collect $33M In TM Fight